1AD
Click for more information
4.00% 2.6¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-14

  1. debono
    23,005 Posts.
    lightbulb Created with Sketch. 827
    clock Created with Sketch.
    08/04/24
    12:44
    Post #: 73238459
    Looking forward to this.

    AdAlta's (ASX:1AD) CEO and MD, Tim Oldham will host a webinar to discuss AdAlta’s new collaboration with SYNthesis BioVentures under a Memorandum of Understanding announced on Monday 8 April 2024 and general business progress | Register https://us02web.zoom.us/webinar/register/WN_86kBPnJVTja6QmLsty2i7Q#/registration… #1AD #Webinar
    1AD Price at posting: 3.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.6¢ 		Change
0.001(4.00%) 		Mkt cap ! $15.48M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $2.302K 90.63K

Buyers (Bids)

No. Vol. Price($)
1 158374 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 437561 2
View Market Depth
Last trade - 15.26pm 28/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.